Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (TA784) (PDF 5.96 MB)

  Published:

  20 April 2022

• Final appraisal determination committee papers (TA784) (PDF 3.61 MB)

  Published:

  20 April 2022

• Appraisal consultation committee papers (TA528) (PDF 12.45 MB)

  Published:

  04 July 2018

• Final appraisal consultation determination committee papers (TA528)  (PDF 3.53 MB)

  Published:

  04 July 2018